Telecommunication-the challenge.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to P B Freeman.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
BACKGROUND: Spectacle mounted telescope low vision aids are designed to magnify objects Spectacle telescopes are often rejected by the visually impaired because of their unusual cosmetic appearance which may call attention to their disability. METHODS: Fifty-six subjects were recruited at four independent low vision clinics and divided into two categories: 24 were current wearers of expanded field spectacle mounted telescope systems, and 32 were new wearers. New wearers underwent a randomized cross-over trial, comparing the experimental device (Ocutech VES) to one of two controls (DFV Expanded Field or Walter's Keplarian Close-focus Telescope). RESULTS: Our data show that previous telescope wearers increased their use of telescopes after introduction of the experimental device (Ocutech VES) and there was an equivalent utilization rate for new wearers. CONCLUSIONS: Visual activity patterns are not a sensitive measure of telescope benefit, but frequency of use patterns do change and appear to demonstrate a valid benefit of spectacle mounted telescopes for the visually impaired.
An NIH-sponsored user and prescriber preference trial was conducted comparing a new low vision telescope system, the Ocutech Vision Enhancing System (VES) to two conventional Keplarian spectacle telescope systems in a controlled cross-over clinical study performed at four independent low vision clinics. Fifty-five visually impaired individuals, 18-81 years of age, with both previous and no telescope experience, were followed for 8-16 weeks. The experimental and control devices were compared on a series of subject-selected visual tasks using a standardized clinical protocol. Subjects were trained in the use of the systems with standardized clinical methods. The data shows a statistically significant preference of the new design by both patient and clinician with the overriding factors relating to appearance, weight, adjustability and the fit of the frame.
The low vision patient is a complex individual who requires understanding by not only the optometrist but by the paraoptometric. The paraoptometric in effect can determine the outcome of the optical portion of the evaluation. By setting the stage for the evaluation, and by carrying out the recommendations, the paraoptometric plays an invaluable role in determining the success of the low vision patient.